Description
Designed to examine the overlap and relative impacts of economics and health in relation to the advancement of tobacco harm reduction.
What are the costs of inappropriate regulation and/or prohibiting the sale and use of safer alternatives to combustible cigarettes?; can healthcare savings linked to safer product availability be quantified?; do falling tobacco tax revenues, or state-involved tobacco income, influence safer product regulation? does overly-restrictive regulation drive independent manufacturers out of business - and disincentivise transnational tobacco industry transitions away from combustibles? These were some of the issues tackled. Building on the success of the #GFNFives, we also introduced the #ScienceLab to the forum, where scientists submit short films describing their work and then have the chance to discuss them with the audience.
We also had Cliff Douglas, the recently-appointed President of Global Action to End Smoking deliver the Michael Russell Oration, looking at ‘Bridging the Divide: Taking Global Action to End Smoking.’
